Overview
John Pimanda practices in Sydney, Australia. Mr. Pimanda is rated as an Advanced expert by MediFind in the treatment of Folate Deficiency. His top areas of expertise are Myelodysplastic Syndrome (MDS), Leukemia, Folate Deficiency, and Acute Myeloid Leukemia (AML).
His clinical research consists of co-authoring 92 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Folate Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)Mr. Pimanda isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Folate DeficiencyMr. Pimanda isAdvanced. Learn about Folate Deficiency.
- LeukemiaMr. Pimanda isAdvanced. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)Mr. Pimanda isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Mr. Pimanda isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- AstrocytomaMr. Pimanda isExperienced. Learn about Astrocytoma.
- Chronic Myelomonocytic Leukemia (CMML)Mr. Pimanda isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Colorectal CancerMr. Pimanda isExperienced. Learn about Colorectal Cancer.
- GlioblastomaMr. Pimanda isExperienced. Learn about Glioblastoma.
- GliomaMr. Pimanda isExperienced. Learn about Glioma.